Drug Research

Hanmi Brings Back Liver Drug After Raising Its Efficacy

After leveraging its microemulsion technology to increase the absorption rate and so address a shortcoming of the original formulation, Hanmi Pharmaceutical has reintroduced its liver function medication. Hanmi from South Korea discovered silymarin, a derivative from the herb milk thistle,...

West Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms

West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, announced it has made a strategic investment in Latch Medical, a Dublin-based leader in next-generation vaccine and biologics delivery technology that is pioneering a...

Thermo Fisher Announced FDA Approves First NGS-Based Companion Diagnostic to Aid in Selecting Non-Small C

The U.S. FDA has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose tumors have a HER2 (ERBB2) activating mutations (SNVs & Exon 20 Insertion) in non-small cell...

Almac Group Announces $65M Expansion of North American Headquarters in Pennsylvania

Almac Group, the global contract development and manufacturing organisation, today announces a $65 million, 100,000 ft2expansion of clinical supply operations at the company’s North American headquarters in Souderton, PA. The capital investment plan increases clinical capacity at the facility...

WuXi Advanced Therapies Announces Licensing Agreement with Janssen

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced a licensing agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (“Janssen”). Under this agreement, WuXi ATU will license to...

3 Viruses The Pharmaceutical Industry Needs To Prepare For

More than half of the known infectious diseases are getting worse due to climate change. Monkeypox is expanding, and recently, news of an outbreak of the Langya henipavirus in China also leaked. Researchers and public health officials are looking...

New Zealand Accelerates Alzheimers Treatment Development

Researchers from the University of Otago in New Zealand have taken advantage of a brain protein that has a strong chance of delaying or reversing the start of Alzheimer's disease. There are currently no viable treatments for Alzheimer's, according...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read